Ultralife Stock Forecast for 2023 - 2025 - 2030

Updated on 05/12/2024

Stock Rating
0
Price Target
$12.00
Consensus
Outperform
Downside
-2.68%
Analysts
0
Stock Rating
0
Downside
-2.68%
Analysts
0
Price Target
$12.00

Ultralife Stock Forecast and Price Target

Given the average yearlong price target of $12.00 provided by prominent analysts over the past few months, there is a potential downside of approximately -2.68% from the last closing price in May, 2024 for Ultralife's stock if it is reached. This estimation is based on a high estimate of $12.00 and a low estimate of $12.00. Even if you are not interested in ULBI stock, it is still crucial to be aware of its competitors.

$12.00

-2.68% Downside

Buy
Buy

Ultralife Fair Value Forecast for 2023 - 2025 - 2030

Ultralife's Price has seen growth In the last three years, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $2.58 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.

2024 Fair Value Forecast
$2.58
2025 Fair Value Forecast
$1.73
2026 Fair Value Forecast
$2.02
2027 Fair Value Forecast
$1.58
2028 Fair Value Forecast
$1.90
2029 Fair Value Forecast
$1.88
2030 Fair Value Forecast
$1.96

Ultralife Revenue Forecast for 2023 - 2025 - 2030

Ultralife's Revenue has seen growth In the last three years, going from $107.71M to $158.64M – a gain of 47.28% In the next year, analysts believe that Revenue will reach $169.50M – an increase of 6.85%. By 2030, professionals predict that Ultralife's Revenue will decrease by 7.34%, to $146.99M.

2024 Rev Forecast
$0.17B
2025 Rev Forecast
$0.14B
2026 Rev Forecast
$0.14B
2027 Rev Forecast
$0.15B
2028 Rev Forecast
$0.15B
2029 Rev Forecast
$0.15B
2030 Rev Forecast
$0.15B

Ultralife Dividend per Share Forecast for 2023 - 2025 - 2030

Ultralife Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.02B

Ultralife EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Ultralife's EBITDA has increased by 54.98%, going from $8.64M to $13.39M. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach $15.60M – an increase of 16.50%. In 2030, professionals predict that Ultralife's EBITDA will decrease by 16.98%, reaching $11.12M.

2024 EBITDA Forecast
$0.02B
2025 EBITDA Forecast
$0.01B
2026 EBITDA Forecast
$0.01B
2027 EBITDA Forecast
$0.01B
2028 EBITDA Forecast
$0.01B
2029 EBITDA Forecast
$0.01B
2030 EBITDA Forecast
$0.01B

Ultralife EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Ultralife's EBIT has grown, increasing from $5.70M to $9.48M – an increase of 66.32%. For next year, the 1 analysts predict EBIT of $12.60M, which would mean an increase of 32.91%. By 2030, professionals believe that Ultralife's EBIT will have decreased by 19.85%, falling to $7.60M.

2024 EBIT Forecast
$0.01B
2025 EBIT Forecast
$0.01B
2026 EBIT Forecast
$0.01B
2027 EBIT Forecast
$0.01B
2028 EBIT Forecast
$0.01B
2029 EBIT Forecast
$0.01B
2030 EBIT Forecast
$0.01B

Ultralife EPS Price Prediction Forecast for 2023 - 2025 - 2030

Ultralife's EPS has seen growth In the last three years, going from $-0.02 to $0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach $0.68 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.

2024 EPS Forecast
$0.68
2025 EPS Forecast
$0.46
2026 EPS Forecast
$0.53
2027 EPS Forecast
$0.42
2028 EPS Forecast
$0.50
2029 EPS Forecast
$0.50
2030 EPS Forecast
$0.52